Product image of Vitrakvi (Larotrectinib) supplied by GNH India

Vitrakvi

Active Ingredient:
Larotrectinib
Origin:
EU

Vitrakvi (Larotrectinib)

Vitrakvi (larotrectinib) is an oral therapy for solid tumors with NTRK gene fusions. This targeted treatment blocks cancer cell growth by inhibiting TRK proteins. Vitrakvi is prescribed after genetic testing confirms NTRK fusion status.

Manufacturer / TM Owner

Bayer Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Vitrakvi is used to treat adults and children with solid tumors that have spread or cannot be removed by surgery. It is prescribed when cancer cells contain an NTRK gene fusion. This targeted therapy works by blocking proteins that help cancer grow. Vitrakvi is often used for rare or advanced cancers that have not responded to other treatments.

Side Effects

  • Vitrakvi may help slow or stop the growth of cancer cells in people with NTRK gene fusions. Some patients experience tumor shrinkage or stabilization of disease. Effects vary by individual and cancer type. Regular monitoring by a healthcare provider is recommended to assess response.

Precautions & Warnings

  • Vitrakvi should be taken exactly as prescribed by a doctor. Keep all appointments for blood tests and imaging to monitor progress. Inform your healthcare provider about all medications and supplements you take. Avoid starting new treatments without consulting your doctor first.

Avoid Interactions

  • Larotrectinib may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Grapefruit products can increase larotrectinib levels in the blood. Certain other medications, including some antibiotics and antifungals, may also interact. Always discuss your full medication list with your doctor.

Frequently Asked Questions

Vitrakvi is used to treat solid tumors in adults and children that have an NTRK gene fusion.

Vitrakvi is taken orally as directed by a healthcare provider, typically in capsule or liquid form.

Common side effects may include fatigue, nausea, dizziness, or joint pain. Your doctor can provide more details.

Some medications may interact with Vitrakvi. Always inform your doctor about all drugs you are taking before starting Vitrakvi.

No, Vitrakvi is a targeted therapy that blocks specific proteins in cancer cells rather than a traditional chemotherapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Larotrectinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT